Genpharm Ltd
14906078
Healthy
- Loss before tax (-10)
Details
Compliance
Last accounts
31/05/2025
total exemption full
Next accounts due
28/02/2027
Confirmation statement
Last: 30/05/2025
Due 13/06/2026
Industry
Officers
secretary · Since 31/05/2023
director · Since 31/05/2023
CHIEF OPERATING OFFICER
BRITISH · UNITED KINGDOM · Age 34
Also on 4 other boards
Persons with Significant Control
Miss Genevieve Boatemaa Boateng
British · United Kingdom · Age 34
128, City Road, London, EC1V 2NX
Notified 31/05/2023
CompanyRankvs 148061+ SIC 70229 peers36
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2025
Turnover
£5k
Annual revenue
Net Worth
£1k
Balance sheet strength
Cash
£1k
Cash in the bank
Profit Before Tax
-£11
Bottom line earnings
Net Current Assets
£1k
Working capital
Current Assets
£1k
Current Liabilities
—
Gross Profit
£5k
Admin Expenses
£5k
Operating Profit
-£11
Profit After Tax
-£11
Balance Sheet
EstimatesDerived
| Year | Implied Profit |
|---|---|
| 2025 | +£0 |
Derived from filed accounts. Not audited figures.